Aihua Yao

1.0k total citations
29 papers, 679 citations indexed

About

Aihua Yao is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Aihua Yao has authored 29 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Hepatology and 8 papers in Oncology. Recurrent topics in Aihua Yao's work include Organ Transplantation Techniques and Outcomes (10 papers), Liver physiology and pathology (7 papers) and Liver Disease and Transplantation (5 papers). Aihua Yao is often cited by papers focused on Organ Transplantation Techniques and Outcomes (10 papers), Liver physiology and pathology (7 papers) and Liver Disease and Transplantation (5 papers). Aihua Yao collaborates with scholars based in China, United States and South Korea. Aihua Yao's co-authors include Xuehao Wang, Beicheng Sun, Liyong Pu, Yun Gao, Xiangcheng Li, Yue Yu, Runqiu Jiang, Guoqiang Li, Ling Lv and Lei Deng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Aihua Yao

27 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aihua Yao China 14 219 198 174 169 169 29 679
Ruiyun Xu China 15 191 0.9× 334 1.7× 92 0.5× 118 0.7× 260 1.5× 36 745
Zhiyong Du China 15 210 1.0× 318 1.6× 49 0.3× 217 1.3× 100 0.6× 38 676
Jiyun Lv China 7 181 0.8× 104 0.5× 100 0.6× 111 0.7× 259 1.5× 9 546
Diego Muilenburg United States 10 84 0.4× 150 0.8× 175 1.0× 118 0.7× 77 0.5× 15 604
Xiaolei Shi China 11 129 0.6× 502 2.5× 103 0.6× 100 0.6× 135 0.8× 14 802
Sachie Nakao Japan 11 179 0.8× 161 0.8× 62 0.4× 43 0.3× 300 1.8× 16 616
S S Wang United States 5 182 0.8× 232 1.2× 96 0.6× 106 0.6× 404 2.4× 8 747
Amanda Mikels‐Vigdal United States 10 92 0.4× 254 1.3× 104 0.6× 206 1.2× 100 0.6× 14 662
Ru Ji China 9 100 0.5× 275 1.4× 81 0.5× 185 1.1× 80 0.5× 18 552

Countries citing papers authored by Aihua Yao

Since Specialization
Citations

This map shows the geographic impact of Aihua Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aihua Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aihua Yao more than expected).

Fields of papers citing papers by Aihua Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aihua Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aihua Yao. The network helps show where Aihua Yao may publish in the future.

Co-authorship network of co-authors of Aihua Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Aihua Yao. A scholar is included among the top collaborators of Aihua Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aihua Yao. Aihua Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Qian, Hongxing Pan, Zhenglun Liang, et al.. (2025). Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China. Nature Communications. 16(1). 2969–2969. 1 indexed citations
2.
Zheng, Hui, Cuidan Li, Aihua Yao, et al.. (2024). Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19. Frontiers in Immunology. 15. 1461419–1461419. 1 indexed citations
3.
4.
Guo, Yongzhong, Dawei Rong, Xiangyi Kong, et al.. (2023). Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study. Journal of Gastrointestinal Oncology. 14(6). 2549–2558. 4 indexed citations
5.
Wu, Chen, Lei Deng, Han Zhuo, et al.. (2020). Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection. Journal of Cellular and Molecular Medicine. 24(17). 10216–10222. 26 indexed citations
6.
Wu, Xiaofeng, Fengjiao Zhao, Hao Wu, et al.. (2020). 170P Sintilimab plus anlotinib as first-line therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC). Annals of Oncology. 31. S1305–S1305. 5 indexed citations
7.
Xia, Yanyan, Aihua Yao, Hongpan Xu, et al.. (2017). Comparison of Two Latex Nanoparticles with Different Diameters and the Application in Detection of Biomarker Golgi Protein 73 in Hepatocellular Carcinoma. Nanoscience and Nanotechnology Letters. 9(3). 398–405. 3 indexed citations
8.
Wang, Ke, Zhengshan Wu, Aihua Yao, et al.. (2015). The Ser326Cys polymorphism of hOGG1 is associated with intrahepatic cholangiocarcinoma susceptibility in a Chinese population.. PubMed. 8(9). 16294–300. 2 indexed citations
9.
Zhang, Biao, Hai Zhang, Dong Wang, et al.. (2014). Never in mitosis gene A-related kinase 6 promotes cell proliferation of hepatocellular carcinoma via cyclin B modulation. Oncology Letters. 8(3). 1163–1168. 17 indexed citations
10.
Jiang, Runqiu, Haiyang Wang, Lei Deng, et al.. (2013). IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer. 13(1). 59–59. 154 indexed citations
11.
Xia, Yongxiang, Jianhua Rao, Aihua Yao, et al.. (2012). Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice. European Journal of Pharmacology. 697(1-3). 117–125. 28 indexed citations
12.
Cui, Yiyao, Jianmin Qian, Aihua Yao, et al.. (2012). SOD Mimetic Improves the Function, Growth, and Survival of Small-Size Liver Grafts After Transplantation in Rats. Transplantation. 94(7). 687–694. 9 indexed citations
13.
Wu, Jindao, Qiyun Tang, Jian Shen, et al.. (2010). Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5. Journal of Hepatology. 53(1). 73–83. 16 indexed citations
14.
Gao, Yun, Aihua Yao, Sen Lu, et al.. (2010). Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice. Oncogene. 29(19). 2784–2794. 78 indexed citations
15.
Yu, Yue, Ling Lü, Xiaofeng Qian, et al.. (2009). Antifibrotic Effect of Hepatocyte Growth Factor-Expressing Mesenchymal Stem Cells in Small-for-Size Liver Transplant Rats. Stem Cells and Development. 19(6). 903–914. 52 indexed citations
16.
Song, Jun, Yewei Zhang, Aihua Yao, et al.. (2008). Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transplant International. 21(4). 372–383. 20 indexed citations
17.
Lu, Ling, Feng Zhang, Liyong Pu, et al.. (2007). Biological features of intrahepatic CD4+CD25+ T cells in the naturally tolerance of rat liver transplantation. PubMed. 1(4). 373–376. 4 indexed citations
18.
Yu, Yue, Aihua Yao, Nian Chen, et al.. (2007). Mesenchymal Stem Cells Over-expressing Hepatocyte Growth Factor Improve Small-for-size Liver Grafts Regeneration. Molecular Therapy. 15(7). 1382–1389. 80 indexed citations
19.
Yao, Aihua, Xiangcheng Li, Liyong Pu, et al.. (2007). Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation. Transplant Immunology. 18(1). 37–43. 24 indexed citations
20.
Pu, Liyong, Xuehao Wang, Feng Zhang, et al.. (2007). Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4+CD25+ regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery. 142(1). 67–73. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruiyun Xu Breakdown of academic impact, for papers by Zhiyong Du Breakdown of academic impact, for papers by Jiyun Lv Breakdown of academic impact, for papers by Diego Muilenburg Breakdown of academic impact, for papers by Xiaolei Shi Breakdown of academic impact, for papers by Sachie Nakao Breakdown of academic impact, for papers by S S Wang Breakdown of academic impact, for papers by Amanda Mikels‐Vigdal Breakdown of academic impact, for papers by Ru Ji
Rankless by CCL
2026